Publicaciones en colaboración con investigadores/as de National Institutes of Health (4)

2019

  1. “Ears of the lynx” MRI sign is associated with SPG11 and SPG15 hereditary spastic paraplegia

    American Journal of Neuroradiology, Vol. 40, Núm. 1, pp. 199-203

2017

  1. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

    The Lancet, Vol. 390, Núm. 10103, pp. 1664-1675

2016

  1. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

    Science Translational Medicine, Vol. 8, Núm. 341

2014

  1. Perceptual decision-making in patients with Parkinson's disease

    Journal of Psychopharmacology, Vol. 28, Núm. 12, pp. 1149-1154